Skip to content

Stock-Based Comp at other companies

ResMed logo
ResMedRMD
$26.79M+11.1%
LivaNova logo
LivaNovaLIVN
$8.27M+6.3%
Globus Medical logo
Globus MedicalGMED
$12.62M-4.5%
Stryker logo
StrykerSYK
$87M+3.6%
ITG
Integer HoldingsITGR
$6.66M-3.2%
Medtronic logo
MedtronicMDT
$95M+6.7%

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
Net margin14.3%+6.4pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Reported directly by Inspire Medical Systems in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's stock-based comp?
Inspire Medical Systems (INSP) reported stock-based comp of $30.69M in Q1 2026.
How has Inspire Medical Systems's stock-based comp changed year-over-year?
Inspire Medical Systems's stock-based comp decreased by 1.2% year-over-year, from $31.06M to $30.69M.
What is the long-term trend for Inspire Medical Systems's stock-based comp?
Over 4 years (2021 to 2025), Inspire Medical Systems's stock-based comp has grown at a 49.4% compound annual growth rate (CAGR), from $26.18M to $130.27M.
What does stock-based comp mean?
Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.